Rapamycin trial news, but I’m keeping my feet on the ground
Posted by brett24 in Longevity & Anti-Aging - 17 points, 6 comments.
This piece says a new Phase 3 rapamycin trial is getting underway to look at immune function. That is the sort of thing I want to see more of, real trials instead of endless hype.
My take, though, is the usual one. Interesting does not mean proven for healthy people trying to slow ageing. Rapamycin still gets talked about like it is some magic longevity switch, and I reckon that is way ahead of the evidence. I am open to it, but I want hard results, side effects, and who actually benefits. Not forum fairy dust.
The bit I keep coming back to is safety. If this ends up helping immune health in older adults, fair enough. But I would still want bloods, proper doctor oversight, and clear answers on dosing and cycling. Does anyone here think rapamycin will end up being more of a niche tool than a mainstream longevity drug?
Comments
- lifter_daily: Yeah, I’m with you on keeping the feet on the ground. The trial is interesting, but it still does not tell us much about healthy people chasing longevity. tbh I think rapamycin may end up being a niche tool, more for specific older groups or particular risk profiles than a broad “longevity” thing. My own take, just from reading around and seeing the chatter, is that the side effect question matters more than the hype. If the benefit is modest and the trade-offs are real, most people will quite
- josh_coldplunge: To be fair, that is exactly where I land too. The boring stuff is the whole story with rapa, infections, lipids, wound healing, mouth ulcers, all of it. I have seen a couple of people in my circle feel fine on low weekly dosing, but that is just their own experience, not proof of anything. If the safety signal is messy, the niche use case makes more sense, right?
- nina489: Exactly. For me that is the real question, not the shiny longevity talk. If the benefit is small, the side effects and who actually tolerates it become the whole story, right? I am waiting for the boring data too, especially infections and wound healing.
- brett24: Spot on, Nina. I’m watching the infection rates like a hawk – any uptick would kill the appeal for me. Same with wound healing; I had a nasty cut last year and it took ages, so any delay would be a red flag. I’ll keep an eye on the trial’s safety tables and see if the side‑effect profile stays within what I’d tolerate.
- brett24: Thanks josh_coldplunge. Yeah the infection risk and mouth ulcers are what keep me cautious. I’d want to see lipid panels and wound healing checks before even trying low weekly dosing. Do you track any bloods while on it, or just go by feel?
- brett24: Fair point about the side‑effects, mate. The trial does list infection rates and lipid changes as secondary endpoints, which is why I’m watching it. In my own low‑dose run (5 mg weekly for a few months) I saw a slight uptick in fasting triglycerides, so I’m keen on those numbers. If the data show anything beyond a marginal benefit, I’ll probably stick to it only if I’m in a higher‑risk bracket. Any thoughts on how long you’d wait for those infection stats before deciding?
Community discussion - research and educational context only. Not medical advice.